Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals

American Journal of Veterinary Research

Volumn 62, Issue 12, 2001, Pages 1870-1875

  Jacks, S ^a   Giguere S ^a   Gronwall, R R ^a   Brown, M P ^a   Merritt, K A ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ANIMAL CELL; ARTICLE; ASSAY; BACTERIUM ISOLATION; BODY FLUID; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIPHTHERIA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HORSE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERITONEAL FLUID; RHODOCOCCUS EQUI; SYNOVIAL FLUID;

ANIMALIA; BACTERIA (MICROORGANISMS); CORYNEBACTERIUM; EQUUS CABALLUS; RHODOCOCCUS EQUI;

EID: 0035203473     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.1870     Document Type: Article

References (37)

1. Azithromycin and clarithromycin: Overview and comparison with erythromycin
2. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution
3. Azithromycin concentrations at the sites of pulmonary infection
4. The pharmacokinetics of azithromycin in human serum and tissues
5. Pharmacokinetics of azithromycin in rats and dogs
6. Clinical microbiology of azithromycin
7. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms
8. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration
9. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals
10. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996)
11. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals
12. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia
13. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
14. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects
15. Fitting curves to data
16. The macrolides: Erythromycin, clarithromycin, and azithromycin
17. High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose
18. Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples
19. Pharmacokinetics of erythromycin in foals and in adult horses
20. Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals
21. Correlation of pharmacokinetic parameters to efficacy of antibiotics: Relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia
22. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model
23. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections
24. Postantibiotic effects and the dosing of macrolides, azalides, and streptogramins
25. Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo
26. Tissue-directed antibiotics and intracellular parasites: Complex interaction of phagocytes, pathogens, and drugs
27. Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture
28. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children
29. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice
30. Intracellular activity of azithromycin against bacterial enteric pathogens
31. The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo
32. Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients
33. Tissue-directed pharmacokinetics
34. Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection
35. The determination of the cellular volume of avian, porcine and bovine phagocytes and bovine mammary epithelial cells and its relationship to uptake of tilmicosin
36. Survival and replication of Rhodococcus equi in macrophages